{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:15:28Z","timestamp":1762982128238,"version":"3.44.0"},"reference-count":48,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2025,8,25]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>To examine the association of the number of controlled risk factors with the excess risk of severe metabolic dysfunction-associated steatotic liver disease (MASLD) and major adverse liver outcomes (MALO) among patients with type 2 diabetes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Research design and methods<\/jats:title>\n                  <jats:p>In this cohort study, a total of 307,688 participants from the UK Biobank were included. Participants with baseline type 2 diabetes were categorized according to the number of risk factors within the guideline-recommended ranges (diet, smoking, drinking, exercise, sedentary behavior, body mass index, glycated hemoglobin, blood pressure, and low-density lipoprotein cholesterol).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>During a median (IQR) of 12.5 (11.8\u201313.2) years of follow-up, 519 (3.9%) participants with type 2 diabetes and 2718 (0.9%) participants without diabetes developed severe MASLD. Patients with type 2 diabetes had an increased risk of severe MASLD compared with participants without diabetes (HR 3.93, 95% CI 3.56 to 4.33), but the excess risk decreased stepwise with an increasing number of risk factors on target (HR (95%\u2009CI) for zero to two controlled risk factors: 5.44 (4.09 to 7.25); three controlled risk factors: 4.47 (3.59 to 5.57); four controlled risk factors: 4.16 (3.49 to 4.96); five controlled risk factors: 3.91 (3.28 to 4.66); six controlled risk factors: 3.50 (2.80 to 4.38); seven to nine controlled risk factors: 2.61 (1.92 to 3.56)). Similar patterns were observed in the analysis of MALO.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Patients with type 2 diabetes who had more controlled risk factors showed progressively lower excess risk of severe MASLD and MALO. Comprehensive interventions targeting multiple risk factors may be associated with reduced liver lesions in patients with type 2 diabetes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjdrc-2025-005336","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T17:24:52Z","timestamp":1757352292000},"page":"e005336","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Association between multifactorial control and excess risk of liver diseases in type 2 diabetes: a prospective cohort study"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3956-8763","authenticated-orcid":false,"given":"Rui","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Social Medicine and Health Management, Huazhong University of Science and Technology School of Public Health, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Social Medicine and Health Management, Huazhong University of Science and Technology School of Public Health, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minzhi","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Social Medicine and Health Management, Huazhong University of Science and Technology School of Public Health, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7838-1996","authenticated-orcid":false,"given":"Yanhong","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Social Medicine and Health Management, Huazhong University of Science and Technology School of Public Health, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfei","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Huazhong University of Science and Technology Tongji Medical College Tongji Hospital, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5020-2984","authenticated-orcid":false,"given":"Xiaoxv","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Social Medicine and Health Management, Huazhong University of Science and Technology School of Public Health, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"2025090810201539000_13.5.e005336.1","unstructured":"International Diabetes Federation . IDF diabetes atlas 2025. 2025. Available: https:\/\/diabetesatlas.org\/resources\/idf-diabetes-atlas-2025"},{"key":"2025090810201539000_13.5.e005336.2","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1962"},{"key":"2025090810201539000_13.5.e005336.3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330110"},{"key":"2025090810201539000_13.5.e005336.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"2025090810201539000_13.5.e005336.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.06.003"},{"key":"2025090810201539000_13.5.e005336.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32511-3"},{"key":"2025090810201539000_13.5.e005336.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155643"},{"key":"2025090810201539000_13.5.e005336.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00796-x"},{"key":"2025090810201539000_13.5.e005336.9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad192"},{"key":"2025090810201539000_13.5.e005336.10","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-S005"},{"key":"2025090810201539000_13.5.e005336.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1800256"},{"key":"2025090810201539000_13.5.e005336.12","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jamacardio.2019.2499","article-title":"Ideal Cardiovascular Health Metrics and Major Cardiovascular Events in Patients With Prediabetes and Diabetes","volume":"4","author":"Wang","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2025090810201539000_13.5.e005336.13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.046783"},{"key":"2025090810201539000_13.5.e005336.14","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/S2666-7568(22)00291-4","article-title":"Association of type 2 diabetes according to the number of risk factors within the recommended range with incidence of major depression and clinically relevant depressive symptoms: a prospective analysis","volume":"4","author":"van Gennip","year":"2023","journal-title":"Lancet Healthy Longev"},{"key":"2025090810201539000_13.5.e005336.15","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03343-w"},{"key":"2025090810201539000_13.5.e005336.16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jhep.2021.09.030","article-title":"Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus","volume":"76","author":"Mallet","year":"2022","journal-title":"J Hepatol"},{"key":"2025090810201539000_13.5.e005336.17","doi-asserted-by":"publisher","DOI":"10.1111\/apt.18254"},{"key":"2025090810201539000_13.5.e005336.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"2025090810201539000_13.5.e005336.19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162388","article-title":"Algorithms for the Capture and Adjudication of Prevalent and Incident Diabetes in UK Biobank","volume":"11","author":"Eastwood","year":"2016","journal-title":"PLoS ONE"},{"key":"2025090810201539000_13.5.e005336.20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31726"},{"key":"2025090810201539000_13.5.e005336.21","first-page":"e2336","article-title":"Association of Combined Healthy Lifestyle Factors With Incident Dementia in Patients With Type 2 Diabetes","volume":"99","author":"Wang","year":"2022","journal-title":"Neurology (ECronicon)"},{"key":"2025090810201539000_13.5.e005336.22","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(18)30200-7"},{"key":"2025090810201539000_13.5.e005336.23","doi-asserted-by":"crossref","DOI":"10.1136\/fmch-2018-000031","article-title":"Study of type 2 diabetes management among patients in a Macau primary care setting","volume":"7","author":"Wong","year":"2019","journal-title":"Fam Med Community Health"},{"key":"2025090810201539000_13.5.e005336.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.01.010"},{"key":"2025090810201539000_13.5.e005336.25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2337\/dc21-1512","article-title":"Association of a Healthy Lifestyle With All-Cause and Cause-Specific Mortality Among Individuals With Type 2 Diabetes: A Prospective Study in UK Biobank","volume":"45","author":"Han","year":"2022","journal-title":"Diabetes Care"},{"key":"2025090810201539000_13.5.e005336.26","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a114001"},{"key":"2025090810201539000_13.5.e005336.27","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.018531"},{"key":"2025090810201539000_13.5.e005336.28","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.88.1.15"},{"key":"2025090810201539000_13.5.e005336.29","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx074"},{"key":"2025090810201539000_13.5.e005336.30","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/kxr047"},{"key":"2025090810201539000_13.5.e005336.31","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.52824","article-title":"Improvement of Social Isolation and Loneliness and Excess Mortality Risk in People With Obesity","volume":"7","author":"Zhou","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2025090810201539000_13.5.e005336.32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.dld.2023.06.025","article-title":"Modifiable lifestyle factors, genetic and acquired risk, and the risk of severe liver disease in the UK Biobank cohort: (Lifestyle factors and SLD)","volume":"56","author":"Liu","year":"2024","journal-title":"Dig Liver Dis"},{"key":"2025090810201539000_13.5.e005336.33","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/j.dsx.2019.05.030","article-title":"Serum Ferritin level, microalbuminuria and non-alcoholic fatty liver disease in type 2 diabetic patients","volume":"13","author":"Amin","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"2025090810201539000_13.5.e005336.34","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0856"},{"key":"2025090810201539000_13.5.e005336.35","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/hep.30083","article-title":"Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People","volume":"68","author":"Pang","year":"2018","journal-title":"Hepatology"},{"key":"2025090810201539000_13.5.e005336.36","doi-asserted-by":"crossref","first-page":"668","DOI":"10.4239\/wjd.v13.i9.668","article-title":"Nonalcoholic fatty liver disease and diabetes","volume":"13","author":"Bellini","year":"2022","journal-title":"World J Diabetes"},{"key":"2025090810201539000_13.5.e005336.37","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-022-01073-0","article-title":"Trends in insulin resistance: insights into mechanisms and therapeutic strategy","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"2025090810201539000_13.5.e005336.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2017.12.005"},{"key":"2025090810201539000_13.5.e005336.39","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330595"},{"key":"2025090810201539000_13.5.e005336.40","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-013-1748-0"},{"key":"2025090810201539000_13.5.e005336.41","doi-asserted-by":"crossref","first-page":"113888","DOI":"10.1016\/j.addr.2021.113888","article-title":"Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"2025090810201539000_13.5.e005336.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.09.020"},{"key":"2025090810201539000_13.5.e005336.43","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0675-0"},{"key":"2025090810201539000_13.5.e005336.44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41586-022-04536-0","article-title":"Obesity alters pathology and treatment response in inflammatory disease","volume":"604","author":"Bapat","year":"2022","journal-title":"Nature New Biol"},{"key":"2025090810201539000_13.5.e005336.45","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau6426","article-title":"ATP release drives heightened immune responses associated with hypertension","volume":"4","author":"Zhao","year":"2019","journal-title":"Sci Immunol"},{"key":"2025090810201539000_13.5.e005336.46","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1038\/s42255-023-00880-1","article-title":"Dynamic lipidome alterations associated with human health, disease and ageing","volume":"5","author":"Hornburg","year":"2023","journal-title":"Nat Metab"},{"key":"2025090810201539000_13.5.e005336.47","doi-asserted-by":"crossref","DOI":"10.4254\/wjh.v17.i1.103409","article-title":"High metabolic dysfunction-associated steatotic liver disease prevalence in type 2 diabetes: Urgent need for integrated screening and lifestyle intervention","volume":"17","author":"Jin","year":"2025","journal-title":"World J Hepatol"},{"key":"2025090810201539000_13.5.e005336.48","doi-asserted-by":"crossref","DOI":"10.1136\/fmch-2024-003154","article-title":"Current and new treatment options for adults recently diagnosed with type 2 diabetes","volume":"13","author":"Oser","year":"2025","journal-title":"Fam Med Community Health"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2025-005336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T17:25:04Z","timestamp":1757352304000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2025-005336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,9,8]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/bmjdrc-2025-005336"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2025-005336","relation":{},"ISSN":["2052-4897"],"issn-type":[{"type":"electronic","value":"2052-4897"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}